CARMA1 controls an early checkpoint in the thymic development of foxP3 + regulatory T cells

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 6736-6743

  Molinero, Luciana L ^a   Yang, Jianying ^b   Gajewski, Thomas ^a   Abraham, Clara ^c   Farrar, Michael A ^b   Alegre, Maria Luisa ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CARMA1 PROTEIN; PROTEIN BCL 10; PROTEIN BCL 2; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR PROTEIN; UNCLASSIFIED DRUG; BCL10 PROTEIN, MOUSE; CARD11 PROTEIN, MOUSE; CASPASE; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MALT1 PROTEIN, MOUSE; MULTIPROTEIN COMPLEX; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MATURATION; CELL PROTECTION; CONTROLLED STUDY; GENE OVEREXPRESSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; THYMUS; TRANSCRIPTION INITIATION; TRANSGENE; ANIMAL; CELL CYCLE; CYTOLOGY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; CASPASES; CELL CYCLE; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 65549146581     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900498     Document Type: Article

References (48)

1. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
2. Khattri, R., T. Cox, S. A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4: 337-342.
3. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
4. Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello, J. A. Beavo, and A. Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775.
5. Lin, W., D. Haribhai, L. M. Relland, N. Truong, M. R. Carlson, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8: 359-368.
6. Caton, A. J., C. Cozzo, J. Larkin, 3rd, M. A. Lerman, A. Boesteanu, and M. S. Jordan. 2004. CD4(+) CD25(+) regulatory T cell selection. Ann. NY Acad. Sci. 1029: 101-114.
7. van Santen, H. M., C. Benoist, and D. Mathis. 2004. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200: 1221-1230.
8. Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J. A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
9. Tang, Q., K. J. Henriksen, E. K. Boden, A. J. Tooley, J. Ye, S. K. Subudhi, X. X. Zheng, T. B. Strom, and J. A. Bluestone. 2003. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171: 3348-3352.
10. Tai, X., M. Cowan, L. Feigenbaum, and A. Singer. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6: 152-162.
11. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
12. D'Cruz, L. M., and L. Klein. 2005. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159.
13. Burchill, M. A., J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar. 2007. IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol 178: 280-290.
14. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17: 167-178.
15. Burchill, M. A., J. Yang, K. B. Vang, J. J. Moon, H. H. Chu, C. W. Lio, A. L. Vegoe, C. S. Hsieh, M. K. Jenkins, and M. A. Farrar. 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28: 112-121.
16. Soper, D. M., D. J. Kasprowicz, and S. F. Ziegler. 2007. IL-2Rβ links IL-2R signaling with Foxp3 expression. Eur. J. Immunol 37: 1817-1826.
17. Vang, K. B., J. Yang, S. A. Mahmud, M. A. Burchill, A. L. Vegoe, and M. A. Farrar. 2008. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181: 3285-3290.
18. Yao, Z., Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, W. T. Watford, A. Laurence, G. W. Robinson, E. M. Shevach, R. Moriggl, et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109: 4368-4375.
19. Bayer, A. L., J. Y. Lee, A. de la Barrera, C. D. Surh, and T. R. Malek. 2008. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J. Immunol. 181: 225-234.
20. Antov, A., L. Yang, M. Vig, D. Baltimore, and L. Van Parijs. 2003. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171: 3435-3441. (Pubitemid 37254544)
21. Burchill, M. A., C. A. Goetz, M. Prlic, J. J. O'Neil, I. R. Harmon, S. J. Bensinger, L. A. Turka, P. Brennan, S. C. Jameson, and M. A. Farrar. 2003. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immunol. 171: 5853-5864.
22. Lio, C. W., and C. S. Hsieh. 2008. A two-step process for thymic regulatory T cell development. Immunity 28: 100-111.
23. Chatila, T. 2008. Molecular mechanisms of regulatory T cell development. J. Clin. Immunol. 28: 625-630.
24. Fontenot, J. D., J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202: 901-906.
25. Liston, A., K. M. Nutsch, A. G. Farr, J. M. Lund, J. P. Rasmussen, P. A. Koni, and A. Y. Rudensky. 2008. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 105: 11903-11908.
26. Weil, R., and A. Israel. 2006. Deciphering the pathway from the TCR to NF-κB. Cell Death Differ. 13: 826-833.
27. Medeiros, R. B., B. J. Burbach, K. L. Mueller, R. Srivastava, J. J. Moon, S. Highfill, E. J. Peterson, and Y. Shimizu. 2007. Regulation of NF-κB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science 316: 754-758.
28. Thome, M., and R. Weil. 2007. Post-translational modifications regulate distinct functions of CARMA1 and BCL10. Trends Immunol. 28: 281-288.
29. Thome, M. 2008. Multifunctional roles for MALT1 in T-cell activation. Nat. Rev. Immunol. 8: 495-500.
30. Schmidt-Supprian, M., J. Tian, E. P. Grant, M. Pasparakis, R. Maehr, H. Ovaa, H. L. Ploegh, A. J. Coyle, and K. Rajewsky. 2004. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl. Acad. Sci. USA 101: 4566-4571.
31. Schmidt-Supprian, M., G. Courtois, J. Tian, A. J. Coyle, A. Israel, K. Rajewsky, and M. Pasparakis. 2003. Mature T cells depend on signaling through the IKK complex. Immunity 19: 377-389.
32. Medoff, B. D., B. P. Sandall, A. Landry, K. Nagahama, A. Mizoguchi, A. D. Luster, and R. J. Xavier. 2009. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 39: 78-84.
33. Gupta, S., S. Manicassamy, C. Vasu, A. Kumar, W. Shang, and Z. Sun. 2008. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol. Immunol. 46: 213-224.
34. Barnes, M. J., P. Krebs, N. Harris, C. Eidenschenk, R. Gonzalez-Quintial, C. N. Arnold, K. Crozat, S. Sovath, E. M. Moresco, A. N. Theofilopoulos, B. Beutler, and K. Hoebe. 2009. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7: e51.
35. Liston, A., and A. Y. Rudensky. 2007. Thymic development and peripheral homeostasis of regulatory T cells. Curr. Opin. Immunol. 19: 176-185.
36. Egawa, T., B. Albrecht, B. Favier, M. J. Sunshine, K. Mirchandani, W. O'Brien, M. Thome, and D. R. Littman. 2003. Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation. Curr. Biol. 13: 1252-1258.
37. Gaide, O., F. Martinon, O. Micheau, D. Bonnet, M. Thome, and J. Tschopp. 2001. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett. 496: 121-127.
38. Bertin, J., L. Wang, Y. Guo, M. D. Jacobson, J. L. Poyet, S. M. Srinivasula, S. Merriam, P. S. DiStefano, and E. S. Alnemri. 2001. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J. Biol. Chem. 276: 11877-11882.
39. Anderson, M. S., E. S. Venanzi, Z. Chen, S. P. Berzins, C. Benoist, and D. Mathis. 2005. The cellular mechanism of Aire control of T cell tolerance. Immunity 23: 227-239.
40. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
41. Algarte, M., P. Lecine, R. Costello, A. Plet, D. Olive, and J. Imbert. 1995. In vivo regulation of interleukin-2 receptor α gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. EMBO J. 14: 5060-5072.
42. Hinz, M., P. Lemke, I. Anagnostopoulos, C. Hacker, D. Krappmann, S. Mathas, B. Dorken, M. Zenke, H. Stein, and C. Scheidereit. 2002. Nuclear factor κB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J. Exp. Med. 196: 605-617.
43. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3: 221-227.
44. Ogilvy, S., D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams. 1999. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. USA 96: 14943-14948.
45. Jun, J. E., L. E. Wilson, C. G. Vinuesa, S. Lesage, M. Blery, L. A. Miosge, M. C. Cook, E. M. Kucharska, H. Hara, J. M. Penninger, et al. 2003. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18: 751-762.
46. Blonska, M., B. P. Pappu, R. Matsumoto, H. Li, B. Su, D. Wang, and X. Lin. 2007. The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 26: 55-66.
47. Molinero, L., P. Zhou, Y. Wang, H. Harlin, J. Cosmano, Y. Yokota, B. Kee, C. Abraham, and M. L. Alegre. 2008. Epidermal Langerhans cells play a major role in skin allograft rejection in mice with NF-κB-impaired T cells. Am. J. Transplant. 8: 21-31.
48. Pennington, D. J., B. Silva-Santos, T. Silberzahn, M. Escorcio-Correia, M. J. Woodward, S. J. Roberts, A. L. Smith, P. J. Dyson, and A. C. Hayday. 2006. Early events in the thymus affect the balance of effector and regulatory T cells. Nature 444: 1073-1077.